Of note, abnormal expression of NDRG1 or NDRG2 has been found in different cancer types, such as in esophageal cancer, colorectal cancer, breast cancer, prostate cancer, and hepatocellular carcinoma, and is significantly associated with poor prognosis (10, 14–16). Here, NDRG2 is linked to hepatocellular carcinoma.